[Characterization of a group of patients with cryptococcosis of the central nervous system]

O Fernandez-Concepción1, C Fernández-Novales, M C Ariosa-Acuña

  • 1Instituto de Neurologia y Neurocirugia, La Habana, Cuba. otmanfc@medscape.com

Revista De Neurologia
|February 25, 2003
PubMed

Insights

Central nervous system cryptococcosis cases increased, with most patients linked to pigeons but not HIV positive. Treatment with amphotericin B cured most, but severe cases and late diagnoses led to sequelae or death.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Epidemiology

Context:

  • Central nervous system (CNS) cryptococcosis incidence has risen, particularly with the AIDS pandemic.
  • The Instituto de Neurología y Neurocirugía in Havana has observed a significant increase in attended cases since 1998.

Purpose:

  • To characterize the clinical and epidemiological profile of hospitalized CNS cryptococcosis patients between 1991 and 2000.
  • To analyze patient demographics, clinical presentations, treatments, and outcomes.

Summary:

  • A descriptive study of 16 adult patients revealed no epidemic outbreaks. 75% had contact with pigeons; none were HIV positive, but 50% had other immunosuppressive conditions.
  • Clinical presentations included meningitis and meningoencephalitis, with headache as the most common initial symptom. Cerebrospinal fluid analysis often showed elevated protein and low cell count.
  • Amphotericin B, sometimes with fluconazole, achieved an 87.5% cure rate. Severe forms and delayed diagnosis correlated with mortality and neurological sequelae.

Impact:

  • Provides insights into the non-HIV associated cryptococcosis epidemiology and clinical spectrum in a specific region.
  • Highlights the importance of early diagnosis and treatment for improving patient outcomes and reducing sequelae in CNS cryptococcosis.
  • Informs clinical management strategies for cryptococcal meningitis and meningoencephalitis, particularly in immunocompromised individuals without HIV.
Abstract